These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 21457123)

  • 1. Urease inhibitors as potential drugs for gastric and urinary tract infections: a patent review.
    Kosikowska P; Berlicki Ł
    Expert Opin Ther Pat; 2011 Jun; 21(6):945-57. PubMed ID: 21457123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ureases as a target for the treatment of gastric and urinary infections.
    Follmer C
    J Clin Pathol; 2010 May; 63(5):424-30. PubMed ID: 20418234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urea, fluorofamide, and omeprazole treatments alter helicobacter colonization in the mouse gastric mucosa.
    Aristoteli LP; O'Rourke JL; Danon S; Larsson H; Mellgard B; Mitchell H; Lee A
    Helicobacter; 2006 Oct; 11(5):460-8. PubMed ID: 16961809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marked reduction of Helicobacter pylori-induced gastritis by urease inhibitors, acetohydroxamic acid and flurofamide, in Mongolian gerbils.
    Ohta T; Shibata H; Kawamori T; Iimuro M; Sugimura T; Wakabayashi K
    Biochem Biophys Res Commun; 2001 Jul; 285(3):728-33. PubMed ID: 11453654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Helicobacter pylori by acetohydroxamic acid.
    Veldhuyzen van Zanten SJ; Goldie J; Hunt RH
    Lancet; 1990 Dec 22-29; 336(8730):1584-5. PubMed ID: 1979397
    [No Abstract]   [Full Text] [Related]  

  • 6. Suppression of Helicobacter pylori-induced gastritis by urease inhibitors in Mongolian gerbils.
    Shibata H; Ohta T; Iimuro M; Kitamura T; Yokokura T; Wakabayashi K
    Gan To Kagaku Ryoho; 2002 Feb; 29 Suppl 1():154-8. PubMed ID: 11890100
    [No Abstract]   [Full Text] [Related]  

  • 7. Acetohydroxamic acid: clinical studies of a urease inhibitor in patients with staghorn renal calculi.
    Griffith DP; Gibson JR; Clinton CW; Musher DM
    J Urol; 1978 Jan; 119(1):9-15. PubMed ID: 23442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helicobacter pylori and plasma ammonia levels in cirrhotics: role of urease inhibition by acetohydroxamic acid.
    Zullo A; Rinaldi V; Hassan C; Folino S; Winn S; Pinto G; Attili AF
    Ital J Gastroenterol Hepatol; 1998 Aug; 30(4):405-9. PubMed ID: 9789138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevention of infected urinary stones by urease inhibitor. IV. Treatment of infection stones in rats by a new hydroxamic acid and cefalexin].
    Takeuchi H; Tomoyoshi T; Okada Y; Yoshida O; Kobashi K
    Hinyokika Kiyo; 1983 Mar; 29(3):297-302. PubMed ID: 6375315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benurestat, a urease inhibitor for the therapy of infected ureolysis.
    Andersen JA
    Invest Urol; 1975 Mar; 12(5):381-6. PubMed ID: 1089613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acetylhydroxamic acid in the treatment of nephrolithiasis, caused by infection with urease forming microorganisms].
    Lorenz J; Lorenz K; Dabrowska B; Kowal R
    Z Urol Nephrol; 1989 Dec; 82(12):685-9. PubMed ID: 2698024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A patent update on therapeutic applications of urease inhibitors (2012-2018).
    Hameed A; Al-Rashida M; Uroos M; Qazi SU; Naz S; Ishtiaq M; Khan KM
    Expert Opin Ther Pat; 2019 Mar; 29(3):181-189. PubMed ID: 30776929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plant-Derived Urease Inhibitors as Alternative Chemotherapeutic Agents.
    Hassan ST; Žemlička M
    Arch Pharm (Weinheim); 2016 Jul; 349(7):507-22. PubMed ID: 27244041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of urease activity in the urinary tract pathogen Staphylococcus saprophyticus.
    Loes AN; Ruyle L; Arvizu M; Gresko KE; Wilson AL; Deutch CE
    Lett Appl Microbiol; 2014 Jan; 58(1):31-41. PubMed ID: 24001038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth-inhibiting, bactericidal, and urease inhibitory effects of Paeonia lactiflora root constituents and related compounds on antibiotic-susceptible and -resistant strains of Helicobacter pylori.
    Ngan LT; Moon JK; Shibamoto T; Ahn YJ
    J Agric Food Chem; 2012 Sep; 60(36):9062-73. PubMed ID: 22891951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, molecular docking and kinetic properties of β-hydroxy-β-phenylpropionyl-hydroxamic acids as Helicobacter pylori urease inhibitors.
    Xiao ZP; Peng ZY; Dong JJ; Deng RC; Wang XD; Ouyang H; Yang P; He J; Wang YF; Zhu M; Peng XC; Peng WX; Zhu HL
    Eur J Med Chem; 2013 Oct; 68():212-21. PubMed ID: 23974021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitors of urease as chemotherapeutic agents.
    Rosenstein IJ; Hamilton-Miller JM
    Crit Rev Microbiol; 1984; 11(1):1-12. PubMed ID: 6373150
    [No Abstract]   [Full Text] [Related]  

  • 18. The synthesis and evaluation of phenoxyacylhydroxamic acids as potential agents for Helicobacter pylori infections.
    Ni WW; Liu Q; Ren SZ; Li WY; Yi LL; Jing H; Sheng LX; Wan Q; Zhong PF; Fang HL; Ouyang H; Xiao ZP; Zhu HL
    Bioorg Med Chem; 2018 Aug; 26(14):4145-4152. PubMed ID: 29983280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3-Arylpropionylhydroxamic acid derivatives as Helicobacter pylori urease inhibitors: Synthesis, molecular docking and biological evaluation.
    Shi WK; Deng RC; Wang PF; Yue QQ; Liu Q; Ding KL; Yang MH; Zhang HY; Gong SH; Deng M; Liu WR; Feng QJ; Xiao ZP; Zhu HL
    Bioorg Med Chem; 2016 Oct; 24(19):4519-4527. PubMed ID: 27492194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Floating microspheres bearing acetohydroxamic acid for the treatment of Helicobacter pylori.
    Umamaheshwari RB; Jain S; Bhadra D; Jain NK
    J Pharm Pharmacol; 2003 Dec; 55(12):1607-13. PubMed ID: 14738585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.